Frier Levitt attorneys presented part 1 of our “Mastering GLP-1 Compounding: Regulatory Insights, Business Strategies, Reimbursement, Telehealth, and Legal Considerations,” a 3-part webinar series designed for pharmacy professionals, including pharmacy owners, pharmacists, and pharmacy technicians. This series offers an in-depth exploration of the current regulatory landscape for compounding pharmacies.
In Part 1, “Understanding FDA Regulations: Key Insights for 503A and 503B Compounding,” the attorneys covered:
- Current Regulatory Environment for 503A and 503B Compounding
- State Laws and State Board of Pharmacy 2023/2024
- Important Regulatory Considerations in the 503B to 503A Compounding
- Model for Community Pharmacies
- 506e Shortages and Beyond
- USP 797/795 Six Months Later
This webinar is part of Frier Levitt’s 3-part series, “Mastering GLP-1 Compounding: Regulatory Insights, Business Strategies, Reimbursement, Telehealth, and Legal Considerations.” Access the entire 3-part webinar series HERE.
